CEACAM5 and neoplasm: Most of the presently used determination tests for tumor markers, like ctDNA, microRNAs, and proteins such as carcinoembryonic antigen (CEA) and prostate-specific antigen (PSA), were developed using qPCR and techniques at the avant-garde, with liquid chromatography coupled to MS [100,101].